Increased cardiomyocyte proliferation benefit depends on the heart injury
In this episode of the Journal of Clinical Investigation, Gerd Hasenfuß, Loren Field, and Karl Toischer discuss their collaborative effort to further evaluate the effect of increased cyclin D2 on outcomes in response to other forms of heart failure.
